Pick a time period -
No more available filters You need to apply a filter before selecting newsroom

Use our filters to get your customized news. Save and subscribe to as many filters as you want, get the news that YOU are interested in right in your mailbox, RSS feed or in your personalized dashboard. Share your stories, news, multimedia and pressreleases and get a wider audience with news.cision.com.

Jakob Lindberg appointed CEO of Oncopeptides

STOCKHOLM — November 15, 2021 — Oncopeptides AB (publ) (Nasdaq Stockholm: ONCO), a biotech company focused on research and development of therapies for difficult-to-treat hematological diseases, today announces that the Board of Directors has appointed Jakob Lindberg as Chief Executive Officer, CEO  of Oncopeptides.  Jakob Lindberg replaces Marty J Duvall, who has been the CEO since July 1, 2020.  These changes are effective immediately.The leadership changes follows the withdrawal of Pepaxto[® ](INN melphalan flufenamide) from the US market and the company’s need to focus its resources on

AcuCort announces that the registration process in the Nordic market is underway for the company’s drug ISICORT®

AcuCort AB (Spotlight Stock Market: ACUC) announced today that the registration process in Denmark, Finland, Iceland and Norway regarding the company’s drug ISICORT® is currently ongoing via a so-called reciprocal procedure, Mutual Recognition Process (MRP). ISICORT® has previously been approved in Sweden.In the development of ISICORT®, the advantages of the commonly prescribed and well-documented anti-inflammatory substance dexamethasone and the administration of a fast-dissolving oral film have been combined into a new drug. The innovative drug has a rapid uptake of the active

FluoGuide A/S publishes interim report for the period January – September 2021

Copenhagen, Denmark, 15 November 2021 – FluoGuide A/S (“FluoGuide” or the “Company”) today releases its results for the period 1 January – 30 September 2021. The Q3 report is available as an attached document to this press release and on FluoGuide’s website.Copenhagen, Denmark, 15 November 2021 – FluoGuide A/S (“FluoGuide” or the “Company”) today releases its results for the period 1 January – 30 September 2021. The Q3 report is available as an attached document to this press release and on FluoGuide’s website. [][]Summary Q3 2021 Q3 2020 Q1-Q3 2021 Q1-Q3 2020

Saab Signs Contract for new Underwater Robot to Ocean Infinity

A contract has been signed with launch-customer Ocean Infinity for the latest Saab underwater robot.Saab, a world leader in underwater robotics, has agreed to sell 10 of its new electric work remotely operated vehicles (eWROV), including further options, to leading marine robotics company, Ocean Infinity. The eWROV is the latest addition to Saab Seaeye’s underwater portfolio used across a variety of offshore energy sectors, ocean science and defence. It is the culmination of four years of research and development, resulting in the largest and most powerful ROV compared to those designed

Autoliv and SSAB collaborate to produce the world’s first fossil-free steel components in automotive safety products

(Stockholm, Sweden, November 15, 2021) – Autoliv, Inc. (NYSE: ALV and SSE: ALIVsdb), the worldwide leader in automotive safety systems, and global steel company SSAB, have initiated a collaboration to research and develop fossil-free steel components for automotive safety products, such as airbags and seatbelts. The collaboration enables Autoliv to be in the forefront in producing automotive safety products with fossil-free steel from SSAB. A new process aims to replace coking coal, traditionally needed for ore-based steelmaking, with hydrogen. The result will be unique: the world's

Karin Schreil takes office as CEO of Ework Group

Today, Karin Schreil takes office as CEO of Ework Group. She succeeds Zoran Covic, who will remain as an advisor to the company's management for a transitional period. “I am very much looking forward to leading the company's continued development together with Ework's employees, clients and consultants. As Northern Europe's leading consulting broker, Ework is perfectly positioned to enable the ongoing digital transition in businesses and society in general,” comments Karin Schreil.Karin Schreil has extensive experience from leading positions in the consulting and talent markets, most

The last day of trading with the warrants of series TO1 in Realfiction Holding AB is today, 15 November 2021

Not for release, publication or distribution in whole or in part, directly or indirectly, in the United States, Australia, Canada, New Zealand, Hong Kong, Japan, Singapore, South Africa, South Korea or any other jurisdiction where such release, publication or distribution would be unlawful or would require registration or any other measures. Please refer to important information at the end of the press release. Today, 15 November 2021, is the last day of trading with the warrants of series TO1 in Realfiction Holding AB (“Realfiction” or the “Company”). The exercise period for the warrants

Johan Rask is appointed CEO of Insplorion

The Board of Insplorion announces today that it has appointed Johan Rask as the new CEO of Insplorion with effect from 1 February 2022. Johan Rask has extensive experience from previous employments and assignments, and the Board considers that he is the right person to drive the company's commercialization work into a new phase.In connection with the current CEO Patrik Dahlqvist being offered interesting opportunities in another industry, the board has after the summer conducted a dialogue with Patrik about the company's needs and focus in the future. Together, it has been concluded that

New data on lecanemab presented at the CTAD Alzheimer conference

Stockholm, November 15, 2021 - BioArctic AB (publ) (Nasdaq Stockholm: BIOA B) and partner Eisai held several oral presentations at the 14[th] Clinical Trials on Alzheimer’s Disease (CTAD) conference, November 9-12, 2021, revealing new data on lecanemab (BAN2401), an investigational anti-amyloid beta protofibril antibody. The presentations provided further support for the encouraging data regarding lecanemab’s potential as a treatment for early Alzheimer’s disease previously seen in the Phase 2b as well as open label extension study. In addition, data presented showed the potential to use

Nightingale launches Nightingale Home and Nightingale Pro service models

Press release15 November 2021 at 9:00 (EET) Nightingale Health Plc (”Nightingale”) launches two new service models: Nightingale Home service model, in which the blood sample is taken by the consumer, and Nightingale Pro service model, in which the blood sample is taken by a healthcare professional at a laboratory. Nightingale Home service model includes the unique health index developed by Nightingale and the health indicators describing different health areas. In the Nightingale Home service model, the sample is taken as a fingerprick blood test with an easy-to-use device.

Hansa Biopharma to initiate Phase 3 study of imlifidase to treat anti-Glomerular Basement Membrane (anti-GBM) disease after successful pre-IND meeting with U.S. FDA

· Pivotal Phase 3 study to commence in 2022 and is expected to enroll approximately 50 patients across the U.S. and Europe · Advice procedure also initiated with the European Medicines Agency · Marks important milestone in the expansion of imlifidase into autoimmune diseases Lund, Sweden November 15, 2021. Hansa Biopharma AB, “Hansa” (Nasdaq Stockholm: HNSA), today announces its decision to initiate a pivotal Phase 3 clinical study of imlifidase to treat anti-GBM disease, following a successful pre-IND (Investigational New Drug) meeting with the U.S. Food and Drug Administration (

SBB sells building rights to a JV together with Aspelin Ramm for SEK 450 million

Samhällsbyggnadsbolaget i Norden AB (publ) (“SBB”) has entered into a binding agreement to sell the property Göteborg Gamlestaden 2:8 for SEK 450m to a newly formed joint venture together with Aspelin Ramm. The property comprises approximately 21,000 sqm as well as additional building rights. “We believe a lot in Gamlestaden in Gothenburg, where we are a major player and where we have recently built a new building for SOS Alarm on the neighboring property. Through this collaboration with the locally strong developer Aspelin Ramm, we are convinced that we will develop the property into

KlaraBo intends to list on Nasdaq Stockholm and carry out a share issue

NOT FOR PUBLICATION, DISTRIBUTION OR RELEASE, IN WHOLE OR IN PART, DIRECTLY OR INDIRECTLY, WITHIN OR INTO THE UNITED STATES, AUSTRALIA, HONG KONG, JAPAN, CANADA, NEW ZEELAND, SWITZERLAND, SINGAPORE, SOUTH AFRICA, OR ANY OTHER JURISDICTION IN WHICH THE PUBLICATION, DISTRIBUTION OR RELEASE WOULD BE UNLAWFUL OR REQUIRE REGISTRATION OR ANY OTHER MEASURES. THIS PRESS RELEASE DOES NOT CONSTITUTE AN OFFER TO ACQUIRE SECURITIES. PLEASE SEE ”IMPORTANT INFORMATION” AT THE END OF THE PRESS RELEASE. KlaraBo Sverige AB (publ) (”KlaraBo” or the ”Company”), a manager and developer of rental apartments

SSAB and Autoliv to collaborate on fossil-free steel in automotive safety products

Steel company SSAB and automotive safety supplier Autoliv have initiated a collaboration to research and develop fossil-free steel components for automotive safety products, such as airbags and seatbelts. Mikael Bratt, CEO of Autoliv (left) and Martin Lindqvist, CEO of SSAB (right). “We are looking forward to working with Autoliv and to start the process of research and development of innovative fossil-free steel components for their automotive safety products. We are initiating a number of pilot projects together with Autoliv with the aim to reduce climate impact and

Stora Enso shares converted

STORA ENSO OYJ STOCK EXCHANGE RELEASE 15 November 2021 at 9.00 EETDuring the 1 October 2021 – 31 October 2021 conversion period there were seven conversions and a total of 3,664 A shares were converted into R shares. The shares were recorded in the Finnish trade register today, 15 November 2021, and trading in the new R shares will start on 16 November 2021.Breakdown of shares after conversion: A shares 176 244 459R shares 612 375 528Total 788 619 987 Each A share and each ten R shares carry one vote. The total amount of votes after the conversion is at least 237 482 011.

UPM included in the Dow Jones Sustainability Index for 10 years in a row

(UPM, Helsinki, 15 November 2021 at 9:00 EET) – UPM has been listed in the Dow Jones European and World Sustainability Indices (DJSI) for 2021-2022 as the only company in its industry. The DJSI indices cover environmental, social and governance aspects of responsibility. “We are delighted and proud that our consistent commitment to sustainability has been recognised in this index for a decade,” says Sami Lundgren, Vice President, UPM Responsibility. “We congratulate UPM for being included in the Dow Jones European and World Sustainability Indices. DJSI distinction is a reflection of

SBB has been assigned a BBB rating with stable outlook from Scope

Scope Ratings GmbH (“Scope”) has assigned a BBB rating with stable outlook to Samhällsbyggnadsbolaget i Norden AB (publ) (“SBB”). According to Scope, the rating is driven by the SBB’s low-risk business model, with a strong asset quality and excellent tenants providing stable and predictable cash flows. “SBB has a strong financial position and we are working hard to continue to provide more information to the market about our low-risk assets. This is our first BBB rating and we feel confident with our journey to achieve a BBB+ rating in short term and an A- rating in the long term,”

Panoro Energy –Invitation to Third Quarter 2021 results presentation

Oslo, 15 November 2021 – The 3Q 2021 trading and financial update to be announced on 22[nd] November will be available on our website http://www.panoroenergy.com at 07:30 a.m. CET. The company will hold a live webinar presentation at 09:00 a.m. CET on Monday 22 November 2021, during which management will discuss the results and operations, followed by a Q&A session. The webinar presentation can be accessed through registering at the link below and the online event will be equipped with features to ask live questions. Joining instructions for participating online or through using local

Storskogen acquires Cuben Utbildning

Storskogen has entered into an agreement to acquire Cuben Utbildning via its subsidiary Strigo. Cuben is a provider of adult- and vocational education in Gothenburg and Stockholm. Cuben reported a turnover of SEK 101m and an EBITA of SEK 14m in 2020. Storskogen expects to complete the acquisition in the end of the fourth quarter of 2021.Cuben offers Swedish for immigrants (“SFI”) and adult- and vocational education. The company also provides labour market education and matching services. Cuben is an add-on acquisition of Strigo, a competence Group with a focus on adult development in life.

Read This 888 Bingo Review Before Signing Up

If you’re in the mood for some online B.I.N.G.O fun, it’s really important that you choose the right bingo site! Not trying to put any pressure on you or anything, but if you choose the wrong site, you could end up with terrible bonuses, tiny jackpots - and rubbish games!  Meanwhile, your best mate is enjoying a £60 welcome bonus, huge Friday night jackpots and a VIP members club! This week, we decided to review 888 Bingo , one of Britain’s most popular bingo sites. Owned by the 888 Group, 888 Bingo has been around for well over a decade. It’

DNB Markets - Isofol Medical: Intensifying precommercial activities

Isofol Medical reported a Q3 operating loss of SEK52m, fairly in line with our forecast loss of SEK49m. The financial position remains solid with end-Q3 cash of SEK421m, which should take the company into 2023e. The next milestone in the ongoing phase III study is when 300 PFS events have occurred, enabling analysis of the data to begin; however, visibility on timing is murky but estimated around end-2021 or early 2022. Top-line data is expected in H1 2022 with a possible approval in H2 2023. The company continues to ramp up its precommercial activities to ensure a swift launch on potential

Fourth Brain Estimates That Bookmakers' Seasonal Promotions Are Easing in 2022

Though sports-betting promotions spiked at the start of the football season, crimping 3Q hold rates and widening book Ebitda losses for Caesars, BetMGM, Penn's Barstool, and DraftKings, costs should ebb and margins recover in 2022 as platforms build customer bases and rival WynnBet cuts promotions, costs should ebb and margins recover in 2022 as platforms build customer bases and rival WynnBet cuts promotions. Caesars, MGM, and Barstool all increased their Pennsylvania freebies in September. It's not unexpected that multiple gaming organizations noted poor sports-book hold rates as a

Correction: Distribution and listing of Tobii Dynavox AB

The previous press release contained contradictory dates regarding the last day of trading in the ordinary shares of Tobii AB (“Tobii”) including the right to receive ordinary shares in Tobii Dynavox AB (“Tobii Dynavox” or the “Company”). Therefore, this press release is published with correct dates. Nasdaq Stockholm’s listing committee has decided that Tobii Dynavox fulfills the applicable listing requirements. Nasdaq Stockholm will approve an application for admission to trading of Tobii Dynavox’s ordinary shares on Nasdaq Stockholm subject to that certain customary conditions are

World Diabetes Day: Latest JDRF Research Moves Closer To Curing Type 1

2021 marks 100 years since the discovery of insulinJDRF , the world's largest non-profit funder of type 1 diabetes research, has launched a campaign tied to World Diabetes Day, showcasing the ongoing daily burden of living with type 1 and the need for further investment into the development of exciting transformational treatments and cures. This year marks the centenary of insulin’s discovery, a scientific breakthrough which has saved the lives of millions of people. However, managing type 1 diabetes with insulin still remains a significant burden for someone with

There are no items matching the current filter
There are no more items matching the current filter
Back to top